Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Mazar, Joseph ^a   Khaitan, Divya ^a   DeBlasio, Dan ^b   Zhong, Cuncong ^b   Govindarajan, Subramaniam S ^a   Kopanathi, Sharmila ^c   Zhang, Shaojie ^b   Ray, Animesh ^c   Perera, Ranjan J ^a  

^a BURNHAM INSTITUTE   (United States)

^b University of Central Florida   (United States)

^c KECK GRADUATE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; MESSENGER RNA; MIRN34 MICRORNA, HUMAN; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINESIS; DISTANT METASTASIS; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; REGIONAL METASTASIS; RNA SEQUENCE; CANCER INVASION; CELL ADHESION; CELL MOTION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; METASTASIS; NORTHERN BLOTTING; PATHOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SKIN TUMOR; TUMOR CELL LINE; WOUND HEALING;

BLOTTING, NORTHERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CPG ISLANDS; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 80052889937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024922     Document Type: Article

References (62)

1. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
2. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, et al. (2007) Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723.
3. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149.
4. Perera RJ, Ray A, (2007) MicroRNAs in the search for understanding human diseases. BioDrugs 21: 97-104.
5. Han L, Witmer PD, Casey E, Valle D, Sukumar S, (2007) DNA methylation regulates MicroRNA expression. Cancer Biol Ther 6: 1284-1288.
6. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
7. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429.
8. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
9. Mueller DW, Rehli M, Bosserhoff AK, (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129: 1740-1751.
10. Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, et al. (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70: 4163-4173.
11. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, et al. (2010) Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One 5: e9685.
12. Segura MF, Belitskaya-Levy I, Rose AE, Zakrzewski J, Gaziel A, et al. (2010) Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res 16: 1577-1586.
13. Ma Z, Lui WO, Fire A, Dadras SS, (2009) Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens. J Mol Diagn 11: 420-429.
14. Mueller DW, Bosserhoff AK, (2009) Role of miRNAs in the progression of malignant melanoma. Br J Cancer 101: 551-556.
15. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, et al. (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68: 2745-2754.
16. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, et al. (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68: 1362-1368.
17. Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, et al. (2010) The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 5: e13779.
18. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, et al. (2010) Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma. Mol Cell.
19. Mazar J, Deblasio D, Govindarajan SS, Zhang S, Perera RJ, (2011) Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. FEBS Lett 585: 2467-2476.
20. Saini HK, Griffiths-Jones S, Enright AJ, (2007) Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci U S A 104: 17719-17724.
21. Zhou X, Ruan J, Wang G, Zhang W, (2007) Characterization and identification of microRNA core promoters in four model species. PLoS Comput Biol 3: e37.
22. Seder CW, Hartojo W, Lin L, Silvers AL, Wang Z, et al. (2009) INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma. J Thorac Oncol 4: 455-462.
23. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, et al. (2010) Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 102: 812-827.
24. Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, et al. (2002) Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim Biophys Acta 1588: 1-6.
25. Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, et al. (2001) Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J 20: 2631-2640.
26. Qian X, Li G, Vass WC, Papageorge A, Walker RC, et al. (2009) The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell 16: 246-258.
27. van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, et al. (2000) Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 156: 769-774.
28. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, et al. (2006) Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25: 5027-5036.
29. Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, et al. (2009) Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 41: 518-520.
30. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288.
31. Weilbach FX, Bogdahn U, Poot M, Apfel R, Behl C, et al. (1990) Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment. Cancer Res 50: 6981-6986.
32. Karnell R, von Schoultz E, Hansson LO, Nilsson B, Arstrand K, et al. (1997) S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma. Melanoma Res 7: 393-399.
33. Felicetti F, Parolini I, Bottero L, Fecchi K, Errico MC, et al. (2009) Caveolin-1 tumor-promoting role in human melanoma. Int J Cancer 125: 1514-1522.
34. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, et al. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68: 4123-4132.
35. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, et al. (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140: 419-430.
36. Streit M, Velasco P, Brown LF, Skobe M, Richard L, et al. (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155: 441-452.
37. Niehrs C, (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481.
38. Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, et al. (2007) The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96: 646-653.
39. Yu B, Yang X, Xu Y, Yao G, Shu H, et al. (2009) Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol 50: 948-957.
40. Lei Z, Li B, Yang Z, Fang H, Zhang GM, et al. (2009) Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4: e7629.
41. Guo L, Liu Y, Bai Y, Sun Y, Xiao F, et al. (2010) Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer 46: 1692-1702.
42. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, et al. (2009) Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28: 4065-4074.
43. Chao A, Tsai CL, Wei PC, Hsueh S, Chao AS, et al. (2010) Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett 291: 99-107.
44. Maun NA, Speicher DW, DiNubile MJ, Southwick FS, (1996) Purification and properties of a Ca(2+)-independent barbed-end actin filament capping protein, CapZ, from human polymorphonuclear leukocytes. Biochemistry 35: 3518-3524.
45. Aspenstrom P, (1997) A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol 7: 479-487.
46. Eden S, Rohatgi R, Podtelejnikov AV, Mann M, Kirschner MW, (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418: 790-793.
47. Tan I, Ng CH, Lim L, Leung T, (2001) Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J Biol Chem 276: 21209-21216.
48. Sigalotti L, Covre A, Fratta E, Parisi G, Colizzi F, et al. (2010) Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. J Transl Med 8: 56.
49. Kelly EJ, Hadac EM, Cullen BR, Russell SJ, (2010) MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS Pathog 6: e1000820.
50. Essa S, Denzer N, Mahlknecht U, Klein R, Collnot EM, et al. (2010) VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. J Steroid Biochem Mol Biol 121: 110-113.
51. Howell PM Jr, Liu S, Ren S, Behlen C, Fodstad O, et al. (2009) Epigenetics in human melanoma. Cancer Control 16: 200-218.
52. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, et al. (2008) Chromatin structure analyses identify miRNA promoters. Genes Dev 22: 3172-3183.
53. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600.
54. Molnar V, Tamasi V, Bakos B, Wiener Z, Falus A, (2008) Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas. Semin Cancer Biol 18: 111-122.
55. Toyota M, Suzuki H, Nishizaka T, Sato A, Yamashita T, (2010) [Molecular mechanisms involved in epigenetic alterations in cancer]. Gan To Kagaku Ryoho 37: 1650-1653.
56. Jonsson A, Tuominen R, Grafstrom E, Hansson J, Egyhazi S, (2010) High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma. J Invest Dermatol 130: 2809-2817.
57. Zhou X-P, Gimm O, Hampel H, Niemann T, Walker MJ, et al. (2000) Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation. Am J Pathol 157: 1123-1128.
58. Bader AG, Brown D, Winkler M, (2010) The promise of microRNA replacement therapy. Cancer Res 70: 7027-7030.
59. Homer N, Merriman B, Nelson SF, (2009) BFAST: an alignment tool for large scale genome resequencing. PLoS One 4: e7767.
60. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, et al. (2010) The UCSC Genome Browser database: update 2010. Nucleic Acids Res 38: D613-619.
61. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
62. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.